Obserwuj
Alexander Roesch
Alexander Roesch
University of Duisburg-Essen
Zweryfikowany adres z uk-essen.de
Tytuł
Cytowane przez
Cytowane przez
Rok
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth
A Roesch, M Fukunaga-Kalabis, EC Schmidt, SE Zabierowski, ...
Cell 141 (4), 583-594, 2010
13122010
Melanoma
D Schadendorf, ACJ Van Akkooi, C Berking, KG Griewank, R Gutzmer, ...
The Lancet 392 (10151), 971-984, 2018
13002018
Cancer stem cell definitions and terminology: the devil is in the details
P Valent, D Bonnet, R De Maria, T Lapidot, M Copland, JV Melo, ...
Nature Reviews Cancer 12 (11), 767-775, 2012
8142012
Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1Bhigh cells
A Roesch, A Vultur, I Bogeski, H Wang, KM Zimmermann, D Speicher, ...
Cancer cell 23 (6), 811-825, 2013
6842013
Melanoma
D Schadendorf, DE Fisher, C Garbe, JE Gershenwald, JJ Grob, A Halpern, ...
Nature reviews Disease primers 1 (1), 1-20, 2015
6582015
Immunotherapy in melanoma: recent advances and future directions
C Franklin, E Livingstone, A Roesch, B Schilling, D Schadendorf
European Journal of Surgical Oncology (EJSO) 43 (3), 604-611, 2017
3032017
Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging
I Stoffels, S Morscher, I Helfrich, U Hillen, J Leyh, NC Burton, ...
Science translational medicine 7 (317), 317ra199-317ra199, 2015
3012015
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised …
L Zimmer, E Livingstone, JC Hassel, M Fluck, T Eigentler, C Loquai, ...
The Lancet 395 (10236), 1558-1568, 2020
2332020
Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases
H Niessner, A Forschner, B Klumpp, JB Honegger, M Witte, A Bornemann, ...
Cancer medicine 2 (1), 76-85, 2013
1472013
Tumor heterogeneity and plasticity as elusive drivers for resistance to MAPK pathway inhibition in melanoma
A Roesch
Oncogene 34 (23), 2951-2957, 2015
1382015
Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population
M Fukunaga-Kalabis, G Martinez, TK Nguyen, D Kim, A Santiago-Walker, ...
Oncogene 29 (46), 6115-6124, 2010
1362010
A comprehensive patient-derived xenograft collection representing the heterogeneity of melanoma
C Krepler, K Sproesser, P Brafford, M Beqiri, B Garman, M Xiao, ...
Cell reports 21 (7), 1953-1967, 2017
1352017
Transcriptional profiling of human endogenous retrovirus group HERV-K (HML-2) loci in melanoma
K Schmitt, J Reichrath, A Roesch, E Meese, J Mayer
Genome biology and evolution 5 (2), 307-328, 2013
1252013
Inverse regulation of melanoma growth and migration by O rai1/STIM 2‐dependent calcium entry
H Stanisz, S Saul, CSL Müller, R Kappl, BA Niemeyer, T Vogt, M Hoth, ...
Pigment cell & melanoma research 27 (3), 442-453, 2014
1142014
Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma
MV Heppt, A Roesch, B Weide, R Gutzmer, F Meier, C Loquai, KC Kähler, ...
European Journal of Cancer 81, 36-44, 2017
1042017
Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient
S Herz, T Höfer, M Papapanagiotou, JC Leyh, S Meyenburg, ...
European journal of cancer 67, 66-72, 2016
1022016
Loss of EphB6 expression in metastatic melanoma
C Hafner, F Bataille, S Meyer, B Becker, A Roesch, M Landthaler, T Vogt
International journal of oncology 23 (6), 1553-1559, 2003
992003
Aetiology, comorbidities and cofactors of chronic leg ulcers: retrospective evaluation of 1 000 patients from 10 specialised dermatological wound care centers in Germany
F Jockenhöfer, H Gollnick, K Herberger, G Isbary, R Renner, M Stücker, ...
International wound journal 13 (5), 821-828, 2016
972016
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas
M Kunz, H Löffler-Wirth, M Dannemann, E Willscher, G Doose, J Kelso, ...
Oncogene 37 (47), 6136-6151, 2018
942018
Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas
A Roesch, B Becker, S Meyer, P Wild, C Hafner, M Landthaler, T Vogt
Modern Pathology 18 (9), 1249-1257, 2005
902005
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20